Capsules Hydraste
Natural health product licensed in Canada
- Licence holder
- Clef des Champs Inc.
- NPN or DIN-HM
- 80016919
- Status
- Active licence
- Licence date
- 22 March 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hydrastis canadensis Source : Racine | 300 mg | Not calculated |
Non-medicinal ingredients
Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Utilisé traditionnellement en herboristerie occidentale pour aider à soulager les catarrhes des muqueuses respiratoires, digestives et génito-urinaires.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Éviter la prise avec des médicaments d'ordonnance, sédatifs et PSN à effets sédatifs, breuvages alcoolisés. Ne pas prendre si vous souffres d'hypertension ou d'une maladie du rein. Ne pas prendre durant la grossesse ou l'allaitement.
Source
Official Health Canada record, licence 80016919
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.